CSF1 and neoplasm: For example, using C–C chemokine 2 (CCL2) to block the recruitment of tumor-associated macrophages/microglia, or the colony-stimulating factor-1 (CSF-1R) inhibitor to impair the survival of macrophages/microglia [20].